Cerebrovascular implications of takayasu arteritis: a review.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Mena Samaan, Arevik Abramyan, Srihari Sundararajan, Emad Nourollah-Zadeh, Hai Sun, Anil Nanda, Sudipta Roychowdhury, Gaurav Gupta
{"title":"Cerebrovascular implications of takayasu arteritis: a review.","authors":"Mena Samaan, Arevik Abramyan, Srihari Sundararajan, Emad Nourollah-Zadeh, Hai Sun, Anil Nanda, Sudipta Roychowdhury, Gaurav Gupta","doi":"10.1007/s00234-024-03472-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Takayasu arteritis (TA) is a rare, chronic, inflammatory large-vessel vasculitis that affects the aorta and its main branches, including the cerebrovascular system. This review analyzes current knowledge and patient outcomes concerning the cerebrovascular implications of TA.</p><p><strong>Methods: </strong>A literature search, with publications from 1994 to 2024, identified pertinent studies through PubMed. An illustrative case report details a 19-year-old female with Type 1 TA, illustrating the complex decision required in the absence of surgical or endovascular options.</p><p><strong>Results: </strong>Our results offer a demographic analysis of 1,698 TA patients, highlighting a female predominance of 89.99% and a mean symptom onset at 33 years. The clinical spectrum of cerebrovascular involvement presented varied symptoms, most notably dizziness, with significant incidences of ischemic events and bilateral stenosis primarily affecting the carotid and subclavian arteries. The most common type of TA was Type V, affecting 40% of patients studied. Endovascular treatment had a 95% initial success rate, with a 67% restenosis rate. Surgical treatment was successful in 84% of cases, but 21% had notable post-operative complications. Similar to the endovascular population, those treated with stand-alone conservative therapy saw a 93% initial remission rate with 52% having relapsed.</p><p><strong>Conclusion: </strong>Assessing the disease activity of TA is crucial when planning vascular intervention due to its significant impact on treatment outcomes. Despite its greater initial invasiveness, surgical interventions showed lower restenosis rates compared to either endovascular interventions or standalone conservative management. We emphasize advancements in TA management and the pressing need for continued research into diagnostic and treatment protocols for improved patient outcomes.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00234-024-03472-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Takayasu arteritis (TA) is a rare, chronic, inflammatory large-vessel vasculitis that affects the aorta and its main branches, including the cerebrovascular system. This review analyzes current knowledge and patient outcomes concerning the cerebrovascular implications of TA.

Methods: A literature search, with publications from 1994 to 2024, identified pertinent studies through PubMed. An illustrative case report details a 19-year-old female with Type 1 TA, illustrating the complex decision required in the absence of surgical or endovascular options.

Results: Our results offer a demographic analysis of 1,698 TA patients, highlighting a female predominance of 89.99% and a mean symptom onset at 33 years. The clinical spectrum of cerebrovascular involvement presented varied symptoms, most notably dizziness, with significant incidences of ischemic events and bilateral stenosis primarily affecting the carotid and subclavian arteries. The most common type of TA was Type V, affecting 40% of patients studied. Endovascular treatment had a 95% initial success rate, with a 67% restenosis rate. Surgical treatment was successful in 84% of cases, but 21% had notable post-operative complications. Similar to the endovascular population, those treated with stand-alone conservative therapy saw a 93% initial remission rate with 52% having relapsed.

Conclusion: Assessing the disease activity of TA is crucial when planning vascular intervention due to its significant impact on treatment outcomes. Despite its greater initial invasiveness, surgical interventions showed lower restenosis rates compared to either endovascular interventions or standalone conservative management. We emphasize advancements in TA management and the pressing need for continued research into diagnostic and treatment protocols for improved patient outcomes.

高安动脉炎对脑血管的影响:综述。
目的:高安动脉炎(TA)是一种罕见的慢性炎症性大血管炎,影响主动脉及其主要分支,包括脑血管系统。这篇综述分析了目前有关TA对脑血管影响的知识和患者的治疗效果:方法:通过PubMed对1994年至2024年发表的文献进行检索,确定了相关研究。一份说明性病例报告详细描述了一名患有 1 型 TA 的 19 岁女性,说明了在没有手术或血管内治疗方案的情况下所需做出的复杂决定:我们的研究结果对 1,698 名 TA 患者进行了人口统计学分析,结果显示女性患者占 89.99%,平均发病年龄为 33 岁。脑血管受累的临床表现多种多样,最明显的症状是头晕,缺血性事件和双侧动脉狭窄的发病率很高,主要影响颈动脉和锁骨下动脉。最常见的TA类型是V型,占所研究患者的40%。血管内治疗的初始成功率为 95%,再狭窄率为 67%。手术治疗在84%的病例中取得了成功,但21%的病例出现了明显的术后并发症。与血管内治疗类似,采用独立保守疗法的患者初始缓解率为93%,52%的患者病情复发:结论:由于TA的疾病活动性对治疗效果有重大影响,因此在计划血管介入治疗时,评估TA的疾病活动性至关重要。尽管手术介入治疗初期创伤较大,但与血管内介入治疗或单独的保守治疗相比,手术介入治疗的再狭窄率较低。我们强调了TA管理方面的进步,以及继续研究诊断和治疗方案以改善患者预后的迫切需要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信